Kidney Effects of Empagliflozin in People with Type 1 Diabetes

David Z I Cherney,Petter Bjornstad,Bruce A Perkins,Julio Rosenstock,Dietmar Neubacher,Jan Marquard,Nima Soleymanlou

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY（2021）

引用 9|浏览28

暂无评分

关键词

kidney protection, kidney function decline, glomerular filtration rate, diabetic kidney disease, diabetes, clinical trial, sodium-glucose co-transporter-2 inhibitor, diabetes mellitus, type 1, empagliflozin, glucosides

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要